Iain Edward Buchan | |
---|---|
Born | |
Occupation(s) | Public health physician, data scientist and academic |
Awards | Florence Nightingale Award, Royal Statistical Society (2023) Alwyn-Smith Medal, Faculty of Public Health (2022) |
Academic background | |
Education | BSc (hons)., Pharmacology (1989) MB ChB., Medicine (1991) MD., Computational statistics (2000) |
Alma mater | University of Liverpool University of Cambridge |
Academic work | |
Institutions | University of Liverpool |
Iain Edward Buchan is a public health physician,data scientist and academic. He holds the W.H. Duncan Chair of Public Health Systems and is Associate Pro Vice Chancellor for Innovation at the University of Liverpool. [1]
Buchan's research focuses on health data science and informatics to enable better prevention,early intervention,and value of care for patients and populations. He has written 337 articles and his work has been cited of 26000 times according to Google Scholar. [2] He is most known for leading the world's first evaluation of mass rapid antigen testing, [3] and the first realistic risk-mitigated reopening of mass events during the UK's response to the COVID-19 pandemic. [4] He also developed the Civic Data Cooperative, [5] which resulted in the Combined Intelligence for Population Health Action (CIPHA) system during the pandemic. [6] He is the recipient of HTN Health Tech Award, [7] Alwyn-Smith Medal, [8] and Florence Nightingale Award. [9]
Buchan is a Fellow of the Faculty of Public Health,the American College of Medical Informatics, [10] British Computer Society and the Faculty of Clinical Informatics. [11] He has also been an advisor to UK,European and international health policy groups, [12] AstraZeneca [13] ) and research organizations including UKRI,Wellcome Trust and the UK National Institute for Health and Care Research (NIHR),for which he is a Senior Investigator. [14]
In the 1980s,Buchan pursued medical training alongside studies in pharmacology and statistical software development. As an undergraduate,he published the first version of a statistical package called "StatsDirect." During the 1990s,as a junior doctor,he researched care pathways,health system dynamics,and care inequities. Later,he trained as a public health consultant while conducting research in medical informatics and pursuing doctoral studies in computational statistics. [15]
Buchan began his academic career in 1992 as an Honorary Clinical Lecturer at the University of Liverpool. He then served as a Research Associate in Medical Informatics at the University of Cambridge in 1996 and Senior Research Fellow in Medical Informatics at Wolfson College,Cambridge in 1997,before training as a Consultant in Public Health. In 2003,he joined the University of Manchester as a Clinical Senior Lecturer in Public Health Intelligence and was promoted in 2008 to Clinical Professor in Public Health Informatics. [16] There,from 2003 to 2017,he founded Health eResearch Centre [17] and co-directed the Farr Institute. [18] In the E-Science movement of the early 2000s he conceived e-Labs and Research Objects, [19] leading to today's Trusted Research Environments and applications in healthcare. [20] At Manchester,he also invented the FARSITE system, [21] helping spin out NW eHealth, [22] and started the #DataSavesLives movement and the Connected Health Cities project. [23]
Subsequently,Buchan served as Director of Healthcare Research at Microsoft Research Cambridge in 2017–2018,producing two patents [24] [25] and furthering the health avatar framework he had conceived eight years earlier. [26]
In 2018,Buchan returned to Liverpool as the University of Liverpool's first chair in Public Health and Clinical Informatics. [1] From 2019 to 2022,he was the founding Executive Dean of the Institute of Population Health at Liverpool,whilst leading research responses to the COVID-19 pandemic. [3] [4] Since 2022,he has been conducting multidisciplinary research partnerships,especially in health technology [27] as Associate Pro Vice Chancellor for Innovation. [1]
Buchan's research areas encompass public health,data science,clinical informatics,epidemiology,and biostatistics. In particular,he has published in areas related to public health challenges,such as inequalities,obesity,mental health and pandemic resilience,and in methodology,including machine learning in epidemiology,research objects in e-science,learning health systems,and the concept of a digital twin/health avatar for healthcare. [2]
Buchan led the world's first evaluation of voluntary mass testing for the SARS-CoV2 antigen with lateral flow devices,working with the British Army,local and national government,public health agencies and the UK's National Health Service. [3] This work provided quick proof that lateral flow devices worked as expected to detect people infected with the COVID-19 virus whether they had symptoms or not. [28] Responding to media debate over the reliability of lateral flow devices,he clarified the evidence regarding a public health test versus a clinical test for COVID-19. [29] The impact of this testing was that COVID-19 hospital admissions fell by 43% initially and 25% overall. [30] The BMJ asked him and colleagues for an accompanying methodology paper on the data analysis as a blueprint of best practice. [31] The UK's universal access community testing policy was shaped by this work,including its demonstration of inequalities in testing uptake and barriers such as digital poverty. [32] He had also formulated a test-to-release daily testing alternative to quarantine for close contacts of cases, [33] which resulted in the Daily Contact Testing policy. [34] He also researched COVID-19 and informed policies in other contexts including care homes, [35] hospitals, [36] schools, [37] and vaccination. [38]
In Spring 2021,Buchan applied previous testing and other COVID-19 risk mitigation research to address the issue of young people being vaccinated last and missing out on social development opportunities due to the continued lockdown of significant cultural events. [39] So,he led a city-scale reopening (after COVID-19 lockdowns) of a cluster of business,nightclub and a music festival events –resulting in minimal SARS-CoV-2 transmission,high levels of enjoyment,low levels of fear over risks,and demonstrated the effectiveness of collaborative strategies for health security at mass cultural gatherings. [40]
Buchan's research has underscored the importance of trust in health data utilization,highlighting transparency,consent,and public involvement, [41] with a specific focus on the role of national governments in the reuse of health data. [42] Building on earlier work in civic data linkage and public health intelligence, [19] [23] he established the first Civic Data Cooperative in Liverpool in late 2019, [5] and put a National Grid of Civic Data Cooperatives forward to the UK Government as means of improving health system innovation and resilience. [43]
Buchan engaged machine learning researchers from Microsoft Research in the field of epidemiology,leading to discoveries pertaining to asthma and allergies. [44] [45] Most recently,he formed the Mental Health Research for Innovation Centre of the UK Government's Mental Health Mission. [27]
Buchan conducted research on other health data science directions including Trusted/Trustworthy Research Environments with Research Objects [20] and eLab networks to improve research reproducibility and tackle the widespread problem of calibration drift in clinical prediction models. [46] He drew attention to the problem of multimorbidity and the need for a unified modelling approach,not only for discovery science but also for personalized care via interactive Health Avatars. [26]
Some of Buchan's most highly cited papers arose from applications of his statistical software to public health problems. [47] He has worked to make better use of routine health record data with combined biostatistics and machine learning approaches to predicting clinical outcomes. [48]
Buchan's data science research has focused on addressing public health challenges,including obesity,inequalities,mental health,and pandemics. He raised a warning over obesity among pre-school children using routinely collected data, [49] then alerted to the high burden of cancer attributable to obesity, [50] then highlighted the challenges of using consumer technology data to understand weight control. [51] He drew attention to the excess of premature deaths in North compared with South England and the need for regional growth incentives. [52] [53] [54] [55]
Cochrane is a British international charitable organisation formed to synthesize medical research findings to facilitate evidence-based choices about health interventions involving health professionals,patients and policy makers. It includes 53 review groups that are based at research institutions worldwide. Cochrane has approximately 30,000 volunteer experts from around the world.
Health informatics is the study and implementation of computer structures and algorithms to improve communication,understanding,and management of medical information. It can be viewed as a branch of engineering and applied science.
Ben Michael Goldacre is a British physician,academic and science writer. He is the first Bennett Professor of Evidence-Based Medicine and director of the Bennett Institute for Applied Data Science at the University of Oxford. He is a founder of the AllTrials campaign and OpenTrials,aiming to require open science practices in clinical trials.
Kamran Abbasi is the editor-in-chief of the British Medical Journal (BMJ),a physician,visiting professor at the Department of Primary Care and Public Health,Imperial College,London,editor of the Journal of the Royal Society of Medicine(JRSM),journalist,cricket writer and broadcaster,who contributed to the expansion of international editions of the BMJ and has argued that medicine cannot exist in a political void.
Sir Iain Geoffrey Chalmers is a British health services researcher,one of the founders of the Cochrane Collaboration,and coordinator of the James Lind Initiative,which includes the James Lind Library and James Lind Alliance.
A lateral flow test (LFT),is an assay also known as a lateral flow device (LFD),lateral flow immunochromatographic assay,or rapid test. It is a simple device intended to detect the presence of a target substance in a liquid sample without the need for specialized and costly equipment. LFTs are widely used in medical diagnostics in the home,at the point of care,and in the laboratory. For instance,the home pregnancy test is an LFT that detects a specific hormone. These tests are simple and economical and generally show results in around five to thirty minutes. Many lab-based applications increase the sensitivity of simple LFTs by employing additional dedicated equipment. Because the target substance is often a biological antigen,many lateral flow tests are rapid antigen tests.
The Enhancing the Quality and Transparency of health research Network is an international initiative aimed at promoting transparent and accurate reporting of health research studies to enhance the value and reliability of medical research literature. The EQUATOR Network is hosted by the University of Oxford,and was established with the goals of raising awareness of the importance of good reporting of research,assisting in the development,dissemination and implementation of reporting guidelines for different types of study designs,monitoring the status of the quality of reporting of research studies in the health sciences literature,and conducting research relating to issues that impact the quality of reporting of health research studies. The Network acts as an "umbrella" organisation,bringing together developers of reporting guidelines,medical journal editors and peer reviewers,research funding bodies,and other key stakeholders with a mutual interest in improving the quality of research publications and research itself. The EQUATOR Network comprises five centres at the University of Oxford,Bond University,Paris Descartes University,Ottawa Hospital Research Institute,and Hong Kong Baptiste University.
Population impact measures (PIMs) are biostatistical measures of risk and benefit used in epidemiological and public health research. They are used to describe the impact of health risks and benefits in a population,to inform health policy.
Remote patient monitoring (RPM) is a technology to enable monitoring of patients outside of conventional clinical settings,such as in the home or in a remote area,which may increase access to care and decrease healthcare delivery costs. RPM involves the constant remote care of patients by their physicians,often to track physical symptoms,chronic conditions,or post-hospitalization rehab.
StatsDirect is a statistical software package designed for biomedical,public health,and general health science uses. The second generation of the software was reviewed in general medical and public health journals.
Andrew Julian Vickers is a biostatistician and attending research methodologist at Memorial Sloan Kettering Cancer Center. Since 2013,he has also been professor of public health at Weill Cornell Medical College. He is the statistical editor for the peer-reviewed journal European Urology.
John Gordon Williams is a British health services researcher and clinical academic gastroenterologist. He led the establishment of the Postgraduate Medical School in Swansea,created and developed the Health Informatics Unit at the Royal College of Physicians,and was the founding president of WAGE,the Welsh Association for Gastroenterology and Endoscopy Williams was appointed a CBE for services to medicine in 2014.
The Zoe Health Study,formerly the COVID Symptom Study,is a health research project of British company Zoe Limited which uses a mobile app that runs on Android and iOS.
Azeem Majeed is a Professor and Head of the Department of Primary Care &Public Health at Imperial College,London,as well as a general practitioner in South London and a consultant in public health. In the most recent UK University Research Excellence Framework results,Imperial College London was the highest ranked university in the UK for the quality of research in the “Public Health,Health Services and Primary Care”unit of assessment.
Gabriel John Scally FFPHM is an Irish public health physician and a former regional director of public health (RDPH) for the south west of England. He is a visiting professor of public health at the University of Bristol and is a member of the Independent SAGE group,formed during the COVID-19 pandemic in 2020. He has also been chair of the trustees of the Soil Association. Previously he was professor of public health and planning,and director of the World Health Organization (WHO) Collaborating Centre for Healthy Urban Environments,both at the University of the West of England (UWE). He was president of the Section of Epidemiology and Public Health of the Royal Society of Medicine,a position he took in 2017.
Long COVID or long-haul COVID is a group of health problems persisting or developing after an initial period of COVID-19 infection. Symptoms can last weeks,months or years and are often debilitating. The World Health Organization defines long COVID as starting three months after the initial COVID-19 infection,but other agencies define it as starting at four weeks after the initial infection.
The AbC-19 rapid antibody test is an immunological test for COVID-19 exposure developed by the UK Rapid Test Consortium and manufactured by Abingdon Health. It uses a lateral flow test to determine whether a person has IgG antibodies to the SARS-CoV-2 virus that causes COVID-19. The test uses a single drop of blood obtained from a finger prick and yields results in 20 minutes. The sensitivity of this test is 98.03% while the specificity is 99.56%. This test is paired with an easy-to-use mobile app which allows a trained professional to generate an antibody test certificate for storing on a person's smartphone.
Nisreen Ala-Din A. S. Alwan MBE is a British–Iraqi public health researcher who is a professor of Public Health at the University of Southampton. Her research considers maternal and child health. During the COVID-19 pandemic,Alwan used social media to communicate public health messages and to call for long covid to be counted and measured. In 2020,Alwan was selected as one of the BBC's top 100 Women.
COVID-19 rapid antigen tests or RATs,also frequently called COVID-19 lateral flow tests or LFTs,are rapid antigen tests used to detect SARS-CoV-2 infection (COVID-19). They are quick to implement with minimal training,cost a fraction of other forms of COVID-19 testing,and give users a result within 5–30 minutes. RATs have been used in several countries as part of mass testing or population-wide screening approaches. Many RATs can be used for self-testing,in which an individual "collects their own specimen…and interpret[s] their test result themselves".
Acoustic epidemiology refers to the study of the determinants and distribution of disease. It also refers to the analysis of sounds produced by the body through a single tool or a combination of diagnostic tools.